Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Stockwatch: 2017, Year Of The Dog

Jan 03 2017

• By Andy Smith

Stockwatch_1200x675 — Andy Smith gives an investor's view of the life sciences sector

Related Content

Biogen/Ionis’s Spinraza Approved; Second Antisense Drug For Neurodegeneration In 2016

Dec 28 2016

Solithera’s Prospects Look Grim Following Complete Response Letter

Dec 30 2016

Acadia's Nuplazid Could Have The Alzheimer's R&D Curse

Dec 21 2016

Stockwatch: What Glimmer Through Yonder Gloom Breaks?

Jul 11 2016

Anthera acquires troubled Sollpura from Lilly

Jul 15 2014

Stockwatch: An Earnings Season Renaissance Fades

Nov 01 2016

Related Companies

Acadia Pharmaceuticals Inc.

Dendreon Corporation

Anthera Pharmaceuticals, Inc.

Eli Lilly and Company

Opko Health

Melinta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

Biogen, Inc.

Additional Topics

Commercial Clinical Trials Rare Diseases Infectious Diseases Neurology BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window